Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-12-23 16:58 Tx date 2022-12-23 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$130.00
+1,000 vol $0.13 each |
1,360,000 | |
Filed 2022-12-23 16:57 Tx date 2022-12-22 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,700
+20,000 vol $0.085 each |
1,359,000 | |
Filed 2022-12-13 20:12 Tx date 2022-12-12 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,680
+32,000 vol $0.115 each |
1,339,000 | |
Filed 2022-12-13 20:09 Tx date 2022-12-09 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250.00
+5,000 vol $0.05 each |
1,307,000 | |
Filed 2022-10-15 02:41 Tx date 2022-10-13 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,125
+15,000 vol $0.075 each |
1,302,000 | |
Filed 2022-09-26 16:41 Tx date 2022-09-26 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$900.00
+9,000 vol $0.10 each |
1,287,000 | |
Filed 2022-09-26 16:40 Tx date 2022-09-22 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,100
+11,000 vol $0.10 each |
1,278,000 | |
Filed 2022-09-21 21:15 Tx date 2022-09-16 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+30,000 vol $0.08 each |
1,267,000 | |
Filed 2022-06-22 18:59 Tx date 2022-06-22 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$420.00
+7,000 vol $0.06 each |
1,237,000 | |
Filed 2022-06-20 04:04 Tx date 2022-06-13 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,650
+30,000 vol $0.055 each |
1,230,000 | |
Filed 2022-06-07 11:16 Tx date 2022-05-16 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$950.00
+10,000 vol $0.095 each |
1,200,000 | |
Filed 2022-06-07 11:15 Tx date 2022-05-13 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,900
+20,000 vol $0.095 each |
1,190,000 | |
Filed 2021-10-25 20:35 Tx date 2021-10-21 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+5,000 vol |
1,170,000 | |
Filed 2021-10-12 20:34 Tx date 2021-10-06 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$14,900
+149,000 vol $0.10 each |
149,000 | |
Filed 2021-10-12 20:33 Tx date 2021-10-04 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-10-12 20:33 Tx date 2021-10-04 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Holder: Gordana Vicentijevic (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2021-10-12 20:32 Tx date 2021-10-04 |
$BCC
Benz Capital Corp. |
Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,165,000 | ||
Filed 2021-10-12 20:14 Tx date 2021-10-06 |
$BCC
Benz Capital Corp. |
Bub, Gordon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+50,000 vol $0.10 each |
50,000 | |
Filed 2021-10-12 14:59 Tx date 2021-10-06 |
$BCC
Benz Capital Corp. |
TINTOR, NICHOLAS
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,000
+100,000 vol $0.10 each |
100,000 | |
Filed 2021-10-12 14:57 Tx date 2021-07-05 |
$BCC
Benz Capital Corp. |
TINTOR, NICHOLAS
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-10-08 20:02 Tx date 2021-10-06 |
$BCC
Benz Capital Corp. |
Bub, Gordon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,500
+25,000 vol $0.10 each |
||
Filed 2021-10-08 20:46 Tx date 2021-10-06 |
$BCC
Benz Capital Corp. |
Pankiw, Christine
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+50,000 vol $0.10 each |
50,000 | |
Filed 2021-10-08 20:45 Tx date 2021-07-05 |
$BCC
Benz Capital Corp. |
Pankiw, Christine
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-10-08 20:44 Tx date 2021-10-06 |
$BCC
Benz Capital Corp. |
Birmingham, Jason
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,500
+75,000 vol $0.10 each |
75,000 | |
Filed 2021-10-08 20:43 Tx date 2021-07-05 |
$BCC
Benz Capital Corp. |
Birmingham, Jason
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-10-08 20:02 Tx date 2021-10-06 |
$BCC
Benz Capital Corp. |
Bub, Gordon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,500
+25,000 vol $0.10 each |
25,000 | |
Filed 2021-10-08 20:00 Tx date 2021-07-05 |
$BCC
Benz Capital Corp. |
Bub, Gordon
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-10-07 13:51 Tx date 2021-10-04 |
$BCC
Benz Capital Corp. |
Escribano, Carlos
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
Filed 2017-10-30 Tx date 2017-08-24 |
$BCC
The Canadian Bioceutical Corporation |
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-20,343,750 vol |
0 | |
Filed 2017-10-30 Tx date 2017-01-19 |
$BCC
The Canadian Bioceutical Corporation |
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
20,343,750 | ||
Filed 2017-10-30 Tx date 2017-08-22 |
$BCC
The Canadian Bioceutical Corporation |
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Shamsa Alotaiba (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-14,437,500 vol |
0 | |
Filed 2017-10-30 Tx date 2017-01-19 |
$BCC
The Canadian Bioceutical Corporation |
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Shamsa Alotaiba (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
14,437,500 | ||
Filed 2017-10-30 Tx date 2017-08-25 |
$BCC
The Canadian Bioceutical Corporation |
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Samih Abdulrahman Basaddiq (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-17,718,750 vol |
0 | |
Filed 2017-10-30 Tx date 2017-01-19 |
$BCC
The Canadian Bioceutical Corporation |
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Samih Abdulrahman Basaddiq (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
17,718,750 | ||
Filed 2017-10-30 Tx date 2017-08-25 |
$BCC
The Canadian Bioceutical Corporation |
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+17,718,750 vol |
52,500,000 | |
Filed 2017-10-30 Tx date 2017-01-19 |
$BCC
The Canadian Bioceutical Corporation |
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
14,437,500 | ||
Filed 2017-10-30 Tx date 2017-08-24 |
$BCC
The Canadian Bioceutical Corporation |
Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+20,343,750 vol |
34,781,250 | |
Filed 2017-10-18 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Stott, Donald
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,000
-100,000 vol $0.05 each |
150,000 | |
Filed 2017-10-18 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Stott, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$30,000
+150,000 vol $0.20 each |
400,000 | |
Filed 2017-10-18 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Stott, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,000
+100,000 vol $0.05 each |
250,000 | |
Filed 2017-10-18 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Stott, Donald
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-30,000
-150,000 vol $0.20 each |
0 | |
Filed 2017-10-17 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$50,000
+250,000 vol $0.20 each |
||
Filed 2017-10-17 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-250,000 vol |
0 | |
Filed 2017-10-17 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-150,000 vol |
250,000 | |
Filed 2017-10-17 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-150,000 vol |
||
Filed 2017-10-17 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,500
+250,000 vol $0.05 each |
2,611,559 | |
Filed 2017-10-17 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$30,000
+150,000 vol $0.20 each |
2,361,559 | |
Filed 2017-10-14 Tx date 2017-10-12 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$30,000
+150,000 vol $0.20 each |
396,000 | |
Filed 2017-10-13 Tx date 2017-10-10 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-30,000
-150,000 vol $0.20 each |
0 | |
Filed 2017-07-04 Tx date 2017-06-29 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$5,250
+105,000 vol $0.05 each |
246,000 | |
Filed 2017-05-06 Tx date 2017-05-05 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,250
-105,000 vol $0.05 each |
150,000 | |
Filed 2017-04-21 Tx date 2016-10-01 |
$BCC
The Canadian Bioceutical Corporation |
Chu, Jonathan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-21 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Chu, Jonathan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+500,000 vol $0.20 each |
500,000 | |
Filed 2017-03-29 Tx date 2017-03-28 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,600
+20,000 vol $0.53 each |
207,500 | |
Filed 2017-03-20 Tx date 2017-03-17 |
$BCC
The Canadian Bioceutical Corporation |
Stott, Donald
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-7,500
-150,000 vol $0.05 each |
250,000 | |
Filed 2017-03-20 Tx date 2017-03-17 |
$BCC
The Canadian Bioceutical Corporation |
Stott, Donald
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,500
+150,000 vol $0.05 each |
150,000 | |
Filed 2017-02-24 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$700,000
+3,500,000 vol $0.20 each |
||
Filed 2017-02-24 Tx date 2017-01-23 |
$BCC
The Canadian Bioceutical Corporation |
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-02-24 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$700,000
+3,500,000 vol $0.20 each |
||
Filed 2017-02-24 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$700,000
+3,500,000 vol $0.20 each |
3,500,000 | |
Filed 2017-02-24 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,100,000
+3,500,000 vol $0.60 each |
7,000,000 | |
Filed 2017-02-24 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,500,000
+3,500,000 vol $1.00 each |
||
Filed 2017-02-24 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,500,000
+3,500,000 vol $1.00 each |
10,500,000 | |
Filed 2017-02-24 Tx date 2017-01-23 |
$BCC
The Canadian Bioceutical Corporation |
Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
|
Promissory Notes
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-02-23 Tx date 2017-02-16 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-62,500 vol |
187,500 | |
Filed 2017-02-23 Tx date 2017-02-16 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-62,500 vol |
||
Filed 2017-02-23 Tx date 2017-02-16 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cindy Eikens-Stafford (Control or Direction)
|
Common Shares
90 - Change in the nature of ownership
|
+62,500 vol |
62,500 | |
Filed 2017-02-23 Tx date 2014-11-18 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cindy Eikens-Stafford (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-02-01 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$700,000
+3,500,000 vol $0.20 each |
3,650,000 | |
Filed 2017-01-31 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,500
+170,000 vol $0.05 each |
250,000 | |
Filed 2017-01-31 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+150,000 vol $0.20 each |
300,000 | |
Filed 2017-01-31 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+150,000 vol $0.20 each |
150,000 | |
Filed 2017-01-31 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,500
-170,000 vol $0.05 each |
0 | |
Filed 2017-01-27 Tx date 2017-01-26 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,500
+30,000 vol $0.05 each |
141,000 | |
Filed 2017-01-26 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Stott, Donald
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+150,000 vol $0.20 each |
400,000 | |
Filed 2017-01-26 Tx date 2016-09-24 |
$BCC
The Canadian Bioceutical Corporation |
Stott, Donald
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-386,265 vol |
250,000 | |
Filed 2017-01-25 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+150,000 vol $0.20 each |
255,000 | |
Filed 2017-01-25 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+150,000 vol $0.20 each |
400,000 | |
Filed 2017-01-06 Tx date 2017-01-03 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-180,000 vol |
2,031,559 | |
Filed 2017-01-06 Tx date 2017-01-03 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
+180,000 vol |
2,211,559 | |
Filed 2017-01-02 Tx date 2016-12-29 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,500
-30,000 vol $0.05 each |
105,000 | |
Filed 2016-10-25 Tx date 2016-10-21 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
+2,211,559 vol |
2,211,559 | |
Filed 2016-10-25 Tx date 2016-10-21 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-2,211,559 vol |
0 | |
Filed 2016-10-24 Tx date 2016-09-24 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-49,800
-166,000 vol $0.30 each |
250,000 | |
Filed 2016-10-24 Tx date 2016-10-21 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Palm American Investments Inc. (Control or Direction)
|
Common Shares
97 - Other
|
-196,771 vol |
0 | |
Filed 2016-09-29 Tx date 2016-09-22 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,750
-35,000 vol $0.05 each |
135,000 | |
Filed 2016-09-29 Tx date 2016-09-22 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Indirect Ownership)
|
Common Shares
51 - Exercise of options
|
$1,750
+35,000 vol $0.05 each |
111,000 | |
Filed 2016-06-20 Tx date 2014-12-16 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,500
+250,000 vol $0.05 each |
||
Filed 2016-06-20 Tx date 2016-06-17 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,000
-80,000 vol $0.05 each |
170,000 | |
Filed 2016-06-20 Tx date 2016-06-17 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-40,000
-80,000 vol $0.50 each |
||
Filed 2016-06-20 Tx date 2014-12-16 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,500
+250,000 vol $0.05 each |
250,000 | |
Filed 2016-06-20 Tx date 2014-11-18 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-20 Tx date 2016-06-17 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,000
+80,000 vol $0.05 each |
80,000 | |
Filed 2016-06-17 Tx date 2016-06-17 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-40,000
-80,000 vol $0.50 each |
170,000 | |
Filed 2016-06-17 Tx date 2014-11-18 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-06-17 Tx date 2014-11-18 |
$BCC
The Canadian Bioceutical Corporation |
Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-05-17 Tx date 2016-05-11 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,000
-40,000 vol $0.05 each |
170,000 | |
Filed 2016-05-17 Tx date 2016-05-11 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$2,000
+40,000 vol $0.05 each |
76,000 | |
Filed 2016-01-13 Tx date 2016-01-11 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-800.00
-4,000 vol $0.20 each |
36,000 | |
Filed 2015-12-24 Tx date 2015-12-23 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-19,500 vol |
2,192,059 | |
Filed 2015-12-24 Tx date 2015-12-23 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
+19,500 vol |
2,211,559 | |
Filed 2015-12-01 Tx date 2015-11-27 |
$BCC
The Canadian Bioceutical Corporation |
BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,500
-125,000 vol $0.18 each |
3,911,000 | |
Filed 2015-11-07 Tx date 2015-11-03 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,250
-25,000 vol $0.05 each |
210,000 | |
Filed 2015-11-07 Tx date 2015-11-03 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,250
+25,000 vol $0.05 each |
40,000 | |
Filed 2015-09-17 Tx date 2015-09-16 |
$BCC
The Canadian Bioceutical Corporation |
BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants CSW - 2014
54 - Exercise of warrants
|
-615,000 vol |
50,000 | |
Filed 2015-09-17 Tx date 2015-09-14 |
$BCC
The Canadian Bioceutical Corporation |
Collagenna skin care products
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$30,750
+615,000 vol $0.05 each |
3,980,000 | |
Filed 2015-09-17 Tx date 2015-03-20 |
$BCC
The Canadian Bioceutical Corporation |
Collagenna skin care products
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,750
+615,000 vol $0.05 each |
3,365,000 | |
Filed 2015-09-17 Tx date 2014-11-19 |
$BCC
The Canadian Bioceutical Corporation |
Collagenna skin care products
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,750,000 | ||
Filed 2015-09-17 Tx date 2015-09-16 |
$BCC
The Canadian Bioceutical Corporation |
BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$30,750
+615,000 vol $0.05 each |
4,036,000 | |
Filed 2015-08-14 Tx date 2015-08-12 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-800.00
-2,000 vol $0.40 each |
2,214,559 | |
Filed 2015-08-14 Tx date 2015-08-13 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,350
-3,000 vol $0.45 each |
2,211,559 | |
Filed 2015-07-31 Tx date 2015-07-29 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,850
-5,000 vol $0.37 each |
2,216,559 | |
Filed 2015-07-15 Tx date 2014-11-18 |
$BCC
The Canadian Bioceutical Corporation |
BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-07-15 Tx date 2015-07-09 |
$BCC
The Canadian Bioceutical Corporation |
BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,750
+150,000 vol $0.185 each |
150,000 | |
Filed 2015-07-15 Tx date 2015-07-14 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,600
-5,000 vol $0.32 each |
2,221,559 | |
Filed 2015-07-10 Tx date 2014-11-18 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-07-10 Tx date 2015-07-06 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-750.00
-15,000 vol $0.05 each |
235,000 | |
Filed 2015-07-10 Tx date 2015-07-06 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$750.00
+15,000 vol $0.05 each |
15,000 | |
Filed 2015-05-22 Tx date 2015-05-21 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,400
-5,000 vol $0.28 each |
2,226,559 | |
Filed 2015-05-13 Tx date 2015-05-13 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-675.00
-2,500 vol $0.27 each |
2,231,559 | |
Filed 2015-05-11 Tx date 2015-05-08 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-130.00
-500 vol $0.26 each |
2,234,059 |